Increased serum CA125 levels in plasma cell dyscrasias

被引:1
|
作者
Iwasaki, T
Hamano, T
Aizawa, K
Kobayashi, K
Kakishita, E
机构
关键词
CA125; extramedullary plasmacytoma; plasma cell dyscrasia; plasma cell leukemia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report 2 cases of plasma cell dyscrasia presenting with significantly elevated serum CA125 levels. The serum levels of CA125 from these patients correlated well with their serum M-protein levels, One patient had an IgG-kappa type extramedullary plasmacytoma with the culture supernatant from lymph node plasma cells showing a considerably high level of CA125 activity. The serum IgG fraction purified using a protein A column was devoid of any detectable CA125 activity, negating that the serum IgG M-protein from this patient might respond with a false-positive result in the CA125 immunoradiometric assay. The other patient had an IgG-lambda type plasma cell leukemia with the culture supernatant from peripheral mononuclear cells also showing a high level of CA125 activity. These observations may suggest that in plasma cell dyscrasias the CA125 antigen is spontaneously produced by tumor cells.
引用
收藏
页码:104 / 108
页数:5
相关论文
共 50 条
  • [21] CA125 SERUM LEVELS AND SECONDARY LAPAROTOMY IN EPITHELIAL OVARIAN-TUMORS
    ROME, RM
    KOH, H
    FORTUNE, D
    CAUCHI, M
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1987, 27 (02): : 142 - 145
  • [22] COMBINED ASSAY OF SERUM LEVELS OF CA125 AND CA19-9 IN ENDOMETRIAL CARCINOMA
    TAKESHIMA, N
    SHIMIZU, Y
    UMEZAWA, S
    HIRAI, Y
    CHEN, JT
    FUJIMOTO, I
    YAMAUCHI, K
    HASUMI, K
    GYNECOLOGIC ONCOLOGY, 1994, 54 (03) : 321 - 326
  • [23] Serum CA125 levels are decreased in rectal cancer but increased in fibrosis-associated diseases and in most types of cancers
    Zhang, Meng
    Zhang, Yiran
    Fu, Jing
    Zhang, Lijuan
    GLYCANS AND GLYCOSAMINOGLYCANS AS CLINICAL BIOMARKERS AND THERAPEUTICS, PT A, 2019, 162 : 241 - 252
  • [24] SERUM CA125 IN PATIENTS WITH ENDOMETRIAL CANCER
    Hashiguchi, Y.
    Yamauchi, M.
    Kasai, M.
    Fukuda, T.
    Ichimura, T.
    Yasui, T.
    Sumi, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A170 - A170
  • [25] LIPOPROTEIN(A) AND CA125 LEVELS IN THE PLASMA OF PATIENTS WITH BENIGN AND MALIGNANT OVARIAN DISEASE
    KUESEL, AC
    KROFT, T
    PREFONTAINE, M
    SMITH, ICP
    INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (03) : 341 - 346
  • [26] Serum CA125 as a biomarker for dysmenorrhea in adenomyosis
    Tang, Ying
    Wen, Ming-Bo
    Xiang, Ru-Mei
    Yang, Ming-Tao
    Shu, Bin
    Xu, Fan
    Li, Jun
    Hu, Hui-Quan
    Shi, Qiuling
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 163 (01) : 131 - 139
  • [27] Serum tetranectin and CA125 in endometrial adenocarcinoma
    Lundstrom, MS
    Hogdall, CK
    Nielsen, AL
    Nyholm, HCJ
    ANTICANCER RESEARCH, 2000, 20 (5C) : 3903 - 3906
  • [28] The predictive value of serum cancer antigen 125 (CA125) levels on pregnancy outcome in threatened miscarriages
    Adeku, Mosunmola A.
    Adegbola, Omololu
    Ajayi, Godwin O.
    JOURNAL OF PERINATAL MEDICINE, 2019, 47 (07) : 704 - 709
  • [29] INCREASED SERUM LEVELS OF CA-125 IN PATIENTS WITH NEPHROTIC SYNDROME
    CALLS, J
    CASES, A
    FILELLA, X
    MOLINA, R
    REVERT, L
    BALLESTA, AM
    NEFROLOGIA, 1993, 13 (02): : 127 - 130
  • [30] INCREASED CATHEPSIN-L LEVELS IN SERUM IN SOME PATIENTS WITH OVARIAN-CANCER - COMPARISON WITH CA125 AND CA72-4
    NISHIDA, Y
    KOHNO, K
    KAWAMATA, T
    MORIMITSU, K
    KUWANO, M
    MIYAKAWA, I
    GYNECOLOGIC ONCOLOGY, 1995, 56 (03) : 357 - 361